Last reviewed · How we verify
NCT03725839
The Evaluation of an Interface for the Treatment of Obstructive Sleep Apnea (OSA)
NA trial testing F&P Interface in Sleep Disordered Breathing in 33 participants. Completed in 30 November 2019.
30 November 2019
Quick facts
| Lead sponsor | Fisher and Paykel Healthcare |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 33 |
| Start date | 5 November 2018 |
| Primary completion | 30 November 2019 |
| Estimated completion | 30 November 2019 |
| Sites | 3 locations across New Zealand |
Drugs / interventions tested
- F&P Interface
Conditions studied
- Sleep Disordered Breathing — all drugs for Sleep Disordered Breathing →
- Obstructive Sleep Apnea — all drugs for Obstructive Sleep Apnea →
Sponsor
Fisher and Paykel Healthcare — full company profile →
Who can join
18 and older, any sex, with Sleep Disordered Breathing or Obstructive Sleep Apnea. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This investigation is designed to evaluate the performance as well as the patients overall acceptance of the interface.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT03725839
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Sleep Disordered Breathing
Currently open trials in the same condition.
- NCT05656365 — Evaluating the Genetics and Immunology of Periodic Fever, Aphthous Stomatitis, Pharyngitis, and Cervical Adenitis (PFAPA · recruiting
- NCT04118387 — Central Sleep Apnea : Physiologic Mechanisms to Inform Treatment · Phase 4 · recruiting
- NCT05589753 — Sleep Disordered Breathing With Opioid Use · Phase 1, PHASE2 · recruiting
- NCT03858244 — Idiopathic Scoliosis Progression and Sleep-disordered Breathing in Children · active not recruiting
Other Fisher and Paykel Healthcare trials
Trials by the same sponsor.
- NCT07484802 — Vela Generation II: Usability and Performance of a Non-Invasive Ventilation Mask. · NA · not yet recruiting
- NCT06939920 — NIV With Airway Washout for Dual Limb Ventilation: Improvement in Minute Ventilation · NA · not yet recruiting
- NCT06738589 — The Inflate Study; Defining the Soft Palate in the Upper Airway Flow Pathway · NA · not yet recruiting
- NCT06670482 — The Effect of Mask Design on Transcutaneous Carbon Dioxide in Healthy Volunteers: A Pilot Clinical Investigation · NA · completed
- NCT06060717 — Evaluation of the F&P Caramel Nasal Mask, US, 2023 · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03725839 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Fisher and Paykel Healthcare
- Last refreshed: 28 February 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03725839.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing